Chief Innovation Officer Michael Stackhouse addresses closed-source-mentality obstacles, the opportunities the open-source community creates, and how the drug development industry will look different building on an open-source foundation.
Chief Innovation Officer Michael Stackhouse addresses closed-source-mentality obstacles, the opportunities the open-source community creates, and how the drug development industry will look different building on an open-source foundation.